Discover the iCAD Virtual Experience

Discover the iCAD Virtual ExperienceClinicians are in need of new solutions to navigate today’s challenges. iCAD is proud to be an integral partner in helping providers and facilities recover from the impact of the COVID-19 pandemic and provide the highest quality patient care.

At iCAD, enhancing patient care is at the center of everything we do. Our suite of AI breast health solutions and the Xoft System are powerful tools that support clinicians in the early detection, risk stratification and treatment of cancer, and empower them to provide quality, cost-effective patient care.

Our technologies are now more relevant than ever, as they offer viable solutions to emerging post-pandemic clinical, economic, and volume-based challenges while optimizing operational efficiency, clinician confidence and patient outcomes.

We are committed to providing you access to the critical information you need, wherever you are. Join us for a virtual experience that brings the latest in our portfolio of leading-edge health solutions right to you.

Post-Pandemic Recovery: How New Technology Can Support Clinicians and Patients in the Aftermath of COVID-19

As we shift from the peak of the pandemic to recovery mode, clinicians are in need of new solutions to navigate today’s challenges. During this virtual event, leading experts from the breast care community will share insights about new innovations in imaging and risk-assessment that may help the clinical community address emerging post-pandemic challenges, and best practices for how facilities can recuperate from the impact of COVID-19. Learn how the latest technology can help clinicians optimize workflow and patient care during the COVID-19 recovery period and beyond.

Date, time and featured panelists to be announced soon.

Educational Webinars

An educational webinar series featuring leading clinical experts in the field of breast radiology and innovative cancer therapy hosted by iCAD

LEARN MORE

Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care. ProFound AI™ is clinically proven to assist radiologists by improving cancer detection, decreasing reading times and reducing false positives and costly patient recalls.

Discover our Cancer Detection and Therapy Solutions

AI Breast Health Solutions

ProFound AI for Digital Breast TomosynthesisProFound AI for Digital Breast TomosynthesisLearn More>ProFound AI for 2D* MammographyProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.Learn More>*CE Mark Approved.
Not available for sale in the U.S.
PowerLook Density AssessmentPowerLook Density AssessmentLearn More>

Xoft® Axxent® Electronic Brachytherapy (eBx®) System®

Breast IORTThe term brachytherapy means "near therapy," or bringing the source of radiation close to the tissue that is targeted.Learn More>

Learn more about how ProFound AI can enhance your practice and patient care today.

Connect with iCAD

Book a virtual experience with one of our experts todayBook a virtual experience with one of our experts todayREGISTERSpeak to a specialist 
today at 1.866.280.2239Speak to a specialist
today at 1.866.280.2239
Contact Us

Explore the Latest Information from iCAD

Clinical Case StudiesClient Case Studies - Imaging for WomenLearn More>VideosVideosLearn More>iNFORMED BlogiNFORMED BlogLearn More>White PapersWhite PapersLearn More>Clinical ArticlesClinical ArticlesLearn More>NewsNews: Press ReleasesLearn More>

Stay Connected

Follow us on social media to stay connected and informed on all the latest iCAD news, virtual events and product announcements.

TwitterFacebookLinkedInYouTube

CONTACT US

© 2020, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

ProFound AI for Digital Breast TomosynthesisProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.

ProFound AI for Digital Breast TomosynthesisProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.

ProFound AI for Digital Breast TomosynthesisProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.

ProFound AI for Digital Breast TomosynthesisProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.

Discover the iCAD Virtual Experience

ProFound AI for Digital Breast TomosynthesisProFound AI for 2D, CE Mark Approved. 
Not available for sale in the U.S.